Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 12, 2008, Pages 1132-1141

  Sanches, R F ^a   Crippa, J A S ^a   Hallak, J E C ^a   de Sousa, J P M ^a   Araujo D ^a   Santos, A C ^a   Zuardi, A W ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cingulate region; Dorsolateral prefrontal cortex; Magnetic resonance spectroscopy; N acetylaspartate; Schizophrenia; Skin conductance

Indexed keywords

ATROPINE; CHLORPROMAZINE; CHOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CREATINE; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUDITORY STIMULATION; CELL VIABILITY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELECTRODERMAL RESPONSE; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NERVE CELL; NEUROBIOLOGY; NEUROIMAGING; PREFRONTAL CORTEX; PROTEIN ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; SKIN CONDUCTANCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

EID: 62749132256     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008001200015     Document Type: Article

References (40)

1. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev 2000; 31: 106-112.
2. Buchsbaum MS, Haier RJ. Psychopathology: biological approaches. Annu Rev Psychol 1983; 34: 401-430.
3. Schell AM, Dawson ME, Rissling A, Ventura J, Subotnik KL, Gitlin MJ, et al. Electrodermal predictors of functional outcome and negative symptoms in schizophrenia. Psychophysiology 2005; 42: 483-492.
4. Dawson ME, Nuechterlein KH, Schell AM, Gitlin M, Ventura J. Autonomic abnormalities in schizophrenia. State or trait indicators? Arch Gen Psychiatry 1994; 51: 813-824.
5. Schell AM, Dawson ME, Nuechterlein KH, Subotnik KL, Ventura J. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects. Psychophysiology 2002; 39: 124-132.
6. Lopes-Machado EZ, Crippa JA, Hallak JE, Guimaraes FS, Zuardi AW. Electrodermically nonresponsive schizophrenic patients make more errors in the Stroop Color Word Test, indicating selective attention deficit. Schizophr Bull 2002; 28: 459-466.
7. Zuardi AW, Borduqui T, Hallak JC, Crippa JA, Araújo D, Santos AC. Grey matter correlates of skin conductance levels in patients with schizophrenia and healthy volunteers: a voxel-based morphometry study. World J Biol Psych 2007; 8: 143.
8. Weiss EM, Golaszewski S, Mottaghy FM, Hofer A, Hausmann A, Kemmler G, et al. Brain activation patterns during a selective attention test - a functional MRI study in healthy volunteers and patients with schizophrenia. Psychiatry Res 2003; 123: 1-15.
9. Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56-71.
10. Matson GB, Weiner M. Spectroscopy. In: Stark DD, Bradley WG (Editors), Magnetic resonance imaging. 3rd edn. St. Louis: Mosby; 1999. p 181-214.
11. Buckley PF, Friedman L. Magnetic resonance spectroscopy. Bridging the neurochemistry and neuroanatomy of schizophrenia. Br J Psychiatry 2000; 176: 203-205.
12. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, et al. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immuno-deficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993; 43: 509-515.
13. Bhakoo KK, Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000; 74: 254-262.
14. Li LM, Cendes F, Antel SB, Andermann F, Serles W, Dubeau F, et al. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol 2000; 47: 195-200.
15. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005; 30: 1949-1962.
16. Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, et al. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 1998; 44: 941-950.
17. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001; 49: 39-46.
18. Sanches RF, Crippa JA, Hallak JE, Araujo D, Zuardi AW. Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology. Rev Hosp Clin Fac Med São Paulo 2004; 59: 145-152.
19. Clarke E, Dewhurst K, Aminoff MJ. An illustrated history of brain function: imaging the brain from antiquity to the present. San Francisco: Norman Pub, 1996.
20. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV axis I disorders - Clinician Version (SCID-CV). Washington: American Psychiatric Press; 1997.
21. Del-Ben CM, Vilela JAA, Crippa JAS, Hallak JEC, Zuardi AW. Confiabilidade teste-reteste da Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica (SCID-CV) traduzida para o português". Rev Bras Psiq 2001; 23: 156-159.
22. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
23. Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl 1986; 326: 1-37.
24. Zuardi AW, Loureiro SR, Rodrigues CRC, Correa AJ, Glock SS. Estudo da estrutura fatorial, fidedignidade e validade da tradução e adaptação para o português da Escala de Avaliação Psiquiátrica Breve (BPRS) Modificada. Rev Assoc Bras Psiq Assoc Psiq Am Lat 1994; 16: 63-68.
25. Crippa JA, Sanches RF, Hallak JE, Loureiro SR, Zuardi AW. A structured interview guide increases Brief Psychiatric Rating Scale reliability in raters with low clinical experience. Acta Psychiatr Scand 2001; 103: 465-470.
26. Oldfield RC. The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971; 9: 97-113.
27. Associação Brasileira de Anunciantes, Associação Nacional das Empresas de Pesquisa de Mercado (ANEP), Associação Brasileira dos Institutos de Pesquisa de Mercado (ABIPEME). Critério de Classificação Sócio-Econômica Brasil (CCSEB). 1997.
28. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
29. Chaves AC, Shirakava I. Escala das síndromes negativa e positiva - PANSS e seu uso no Brasil. Rev Psiquiatr Clín 1998; 25: 337-343.
30. Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull 1997; 21: 224-226.
31. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997; 154: 688-690.
32. Deicken RF, Zhou L, Schuff N, Weiner MW. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr Res 1997; 27: 65-71.
33. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10: 1078-1092.
34. Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, et al. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 2003; 64: 63-71.
35. Premkumar P, Fannon D, Kuipers E, Cooke MA, Simmons A, Kumari V. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia. Behav Brain Res 2008; 193: 132-139.
36. Marquardt RK, Levitt JG, Blanton RE, Caplan R, Asarnow R, Siddarth P, et al. Abnormal development of the anterior cingulate in childhood-onset schizophrenia: a preliminary quantitative MRI study. Psychiatry Res 2005; 138: 221-233.
37. Perry W, Felger T, Braff D. The relationship between skin conductance hyporesponsivity and perseverations in schizophrenia patients. Biol Psychiatry 1998; 44: 459-465.
38. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 2000; 41: 389-395.
39. Critchley HD, Good CD, Ashburner J, Frackowiak RS, Mathias CJ, Dolan RJ. Changes in cerebral morphology consequent to peripheral autonomic denervation. Neuroimage 2003; 18: 908-916.
40. Critchley HD, Melmed RN, Featherstone E, Mathias CJ, Dolan RJ. Brain activity during biofeedback relaxation: a functional neuroimaging investigation. Brain 2001; 124: 1003-1012.